489 related articles for article (PubMed ID: 26191151)
1. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
2. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.
Rodrigues PG; Bringhenti RN; do Nascimento JF; Joelsons G; dos Santos M; Pereira S; Veronese FV
Int J Clin Exp Pathol; 2014; 7(5):2185-98. PubMed ID: 24966927
[TBL] [Abstract][Full Text] [Related]
4. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
5. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
6. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.
Avihingsanon Y; Phumesin P; Benjachat T; Akkasilpa S; Kittikowit V; Praditpornsilpa K; Wongpiyabavorn J; Eiam-Ong S; Hemachudha T; Tungsanga K; Hirankarn N
Kidney Int; 2006 Feb; 69(4):747-53. PubMed ID: 16518330
[TBL] [Abstract][Full Text] [Related]
7. Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.
Wang G; Lai FM; Tam LS; Li KM; Lai KB; Chow KM; Li KT; Szeto CC
J Rheumatol; 2007 Dec; 34(12):2358-64. PubMed ID: 17985404
[TBL] [Abstract][Full Text] [Related]
8. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
[TBL] [Abstract][Full Text] [Related]
9. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
Yuan M; Tan Y; Wang Y; Wang SX; Yu F; Zhao MH
Lupus; 2019 Mar; 28(3):347-358. PubMed ID: 30755145
[TBL] [Abstract][Full Text] [Related]
10. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
11. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
Rezende GM; Viana VS; Malheiros DM; Borba EF; Silva NA; Silva C; Leon EP; Noronha IL; Bonfa E
Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611
[TBL] [Abstract][Full Text] [Related]
12. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology.
Perysinaki GS; Moysiadis DK; Bertsias G; Giannopoulou I; Kyriacou K; Nakopoulou L; Boumpas DT; Daphnis E
Lupus; 2011 Jul; 20(8):781-91. PubMed ID: 21478284
[TBL] [Abstract][Full Text] [Related]
13. Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
Lopes TG; de Souza ML; da Silva VD; Dos Santos M; da Silva WIC; Itaquy TP; Garbin HI; Veronese FV
PLoS One; 2019; 14(6):e0217585. PubMed ID: 31220088
[TBL] [Abstract][Full Text] [Related]
14. Increased urine podocyte-associated messenger RNAs in severe obesity are evidence of podocyte injury.
Pereira SV; Dos Santos M; Rodrigues PG; do Nascimento JF; Timm JR; Zancan R; Friedman R; Veronese FV
Obesity (Silver Spring); 2015 Aug; 23(8):1643-9. PubMed ID: 26147062
[TBL] [Abstract][Full Text] [Related]
15. Value of immunohistochemical expression of podocalyxin in active lupus nephritis.
Behairy MA; Shakweer MM; El Said TW; ElGharbawy NH
Nefrologia (Engl Ed); 2018; 38(1):64-72. PubMed ID: 28757276
[TBL] [Abstract][Full Text] [Related]
16. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.
Wang G; Lai FM; Tam LS; Li EK; Kwan BC; Chow KM; Li PK; Szeto CC
Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162
[TBL] [Abstract][Full Text] [Related]
17. Urine podocyte mRNAs mark progression of renal disease.
Sato Y; Wharram BL; Lee SK; Wickman L; Goyal M; Venkatareddy M; Chang JW; Wiggins JE; Lienczewski C; Kretzler M; Wiggins RC
J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856
[TBL] [Abstract][Full Text] [Related]
18. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus.
Lu J; Hu ZB; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ma KL
BMC Nephrol; 2019 Aug; 20(1):303. PubMed ID: 31382919
[TBL] [Abstract][Full Text] [Related]
19. Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis.
Avihingsanon Y; Benjachat T; Tassanarong A; Sodsai P; Kittikovit V; Hirankarn N
Kidney Int; 2009 Jun; 75(12):1340-1348. PubMed ID: 19295501
[TBL] [Abstract][Full Text] [Related]
20. Urinary podocytes for the assessment of disease activity in lupus nephritis.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Sekizuka K; Ebihara I; Koide H
Am J Med Sci; 2000 Aug; 320(2):112-6. PubMed ID: 10981486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
